KLK3 and benign prostatic hyperplasia: Therefore, a study was initiated on men with symptomatic benign prostatic hyperplasia to investigate the effects of oral doses of lonidamine on prostate volume, prostate-specific antigen, and urine flow (Roehrborn 2005).